[1] Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al. Adenoid cystic carcinoma of the head and neck-An update[J]. Oral Oncol, 2015, 51(7):652-661. [2] 邹会会,徐文光,尹西腾,等.基于SEER数据库分析影响大唾液腺腺样囊性癌患者预后的临床病理因素[J].口腔医学研究,2020,36(2):167-171. [3] 邵喆,江希松,宋凯,等.腺样囊性癌嗜神经侵袭体外模型的建立[J].口腔医学研究,2014,30(3):209-211. [4] Sood S, McGurk M, Vaz F. Management of salivary gland tumours: United Kingdom National multidisciplinary guidelines[J]. J Laryngol Otol, 2016,130(S2):S142-S149. [5] Atallah S, Casiraghi O, Fakhry N, et al. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors[J]. Eur J Cancer, 2020, 130:241-249. [6] Seok J, Lee DY, Kim WS, et al. Lung metastasis in adenoid cystic carcinoma of the head and neck[J]. Head Neck, 2019, 41(11):3976-3983. [7] Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability[J]. Carcinogenesis, 2009, 30(7):1073-1081. [8] Huang X, Hu H, Zhang W, et al. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma[J]. J Cell Physiol, 2019, 234(10):18408-18414. [9] Huang ZZ, Hua X, Song CG, et al. The prognostic prediction value of systemic inflammation score and the development of a nomogram for patients with surgically treated breast cancer[J]. Front Oncol, 2020, 10:563731. [10] Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: A retrospective multicenter cohort study[J]. Ann Surg, 2019, 270(1):139-146. [11] El Sharouni MA, Ahmed T, Varey AHR, et al. Development and validation of nomograms to predict local, regional, and distant recurrence in patients with thin (T1) melanomas[J]. J Clin Oncol, 2021, 39(11): 1243-1252. [12] Serenari M, Han KH, Ravaioli F, et al. A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma[J]. J Hepatol, 2020, 73(4): 855-862. [13] Cavalieri S, Mariani L, Vander PV, et al. Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands[J]. Eur J Cancer, 2020, 136:35-42. [14] Greten FR, Grivennikov SI. Inflammation and cancer: Triggers, mechanisms, and consequences[J]. Immunity, 2019, 51(1):27-41. [15] Chen L, Hao Y, Cong X, et al. Peripheral venous blood platelet-to-lymphocyte ratio (PLR) for predicting the survival of patients with gastric cancer treated with SOX or XELOX regimen neoadjuvant chemotherapy[J]. Technol Cancer Res Treat, 2019, 18:1533033819829485. [16] Sharma D, Brummel-Ziedins KE, Bouchard BA, et al. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer[J]. J Cell Physiol, 2014, 229(8):1005-1015. [17] Zhang H, Xu L, Xiao D, et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion[J]. J Clin Pathol, 2007, 60(5):555-561. [18] Trellakis S, Farjah H, Bruderek K, et al. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors[J]. Int J Immunopathol Pharmacol, 2011, 24(3):683-693. [19] DeNardo DG, Johansson M, Coussens LM. Immune cells as mediators of solid tumor metastasis[J]. Cancer Metastasis Rev, 2008, 27(1):11-18. [20] Curtis LT, Sebens S, Frieboes HB. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment[J]. Cancer Immunol Immunother, 2021, 70(5):1475-1488. [21] Amit M, Binenbaum Y, Sharma K, et al. Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study[J]. Head Neck, 2014, 36(7):998-1004. [22] Oplatek A, Ozer E, Agrawal A, et al. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection[J]. Laryngoscope, 2010, 120(1):65-70. [23] Chang H, Lee HJ, Mo JH, et al. Clinical implication of the olfactory cleft in patients with chronic rhinosinusitis and olfactory loss[J]. Arch Otolaryngol Head Neck Surg, 2009, 135(10):988-992. |